Streamline Health Solutions (NASDAQ:STRM) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report released on Friday. The firm issued a sell rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Stock Up 7.6 %

Shares of NASDAQ:STRM opened at $3.39 on Friday. The firm has a market cap of $14.32 million, a PE ratio of -0.69 and a beta of 1.67. The company has a fifty day simple moving average of $2.76 and a 200 day simple moving average of $5.11. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.61) earnings per share (EPS) for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.